Source link : https://newshealth.biz/health-news/new-drug-for-rare-neuroendocrine-tumors-shows-durable-activity/
(MedPage Today) — BERLIN — Belzutifan (Welireg) induced durable responses in advanced pheochromocytoma or paraganglioma (PPGL) in a single-arm phase II trial, evidence that supported FDA’s recent approval in these very rare neuroendocrine tumors… Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118019 Author : Publish date : 2025-10-18 21:17:00 Copyright for syndicated content belongs to the linked Source.
The post New Drug for Rare Neuroendocrine Tumors Shows Durable Activity first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-18 21:17:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8